✦ LIBER ✦

P1.208 Randomized placebo-controlled trial of memantine for dementia in Parkinson's disease

✍ Scribed by L. Marsh; K. Biglan; J.R. Williams

Book ID: 117753533
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70330-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized controlled trial of memantine

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

✍ Iracema Leroi; Ross Overshott; E. Jane Byrne; Emily Daniel; Alistair Burns 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

## Abstract The objective of this study is to investigate the safety and tolerability of memantine, a glutamatergic modulator, in patients suffering from dementia associated with Parkinson's disease (PDD), an increasingly common complication of PD. This was a 22‐week trial of 25 participants with a

Memantine for patients with Parkinson's

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

✍ Murat Emre; Magda Tsolaki; Ubaldo Bonuccelli; Alain Destée; Eduardo Tolosa; Alex 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 280 KB

Randomized controlled trial of memantine

Randomized controlled trial of memantine for agitation in dementia

✍ Fox, Chris; Maidment, Ian; Crugel, Monica; Katona, Cornelius; Livingston, Gill; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Memantine in patients with Parkinson's d

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

✍ Dag Aarsland; Clive Ballard; Zuzana Walker; Fredrik Bostrom; Guido Alves; Katja 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 153 KB

Randomized placebo-controlled trial of d

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease

✍ Iracema Leroi; Jason Brandt; Stephen G. Reich; Constantine G. Lyketsos; Stephen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Objective To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD). ## Methods Using a randomized, double‐blind, placebo‐controlled design, nine patients rec

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease

✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s